Invesco

Invesco’s Capricor Therapeutics CAPR Stock Holding History

Invesco’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.64M	Buy	185,372 +171,751	+1,261%	+$4.58M	﹤0.01%	2143
2025 Q4	$393K	Sell	13,621 -34	-0.2%	-$444	﹤0.01%	3285
2025 Q3	$98.5K	Sell	13,655 -869	-6%	-$6.4K	﹤0.01%	3687
2025 Q2	$144K	Buy	14,524 +276	+2%	+$2.92K	﹤0.01%	3596
2025 Q1	$135K	Sell	14,248 -430	-3%	-$5.97K	﹤0.01%	3588
2024 Q4	$203K	Buy	14,678 +2,500	+21%	+$43.8K	﹤0.01%	3508
2024 Q3	$185K	Buy	12,178 +44	+0.4%	+$218	﹤0.01%	3531
2024 Q2	$57.9K	Buy	+12,134	New	+$67.7K	﹤0.01%	3806

Other funds holding CAPR

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jones Hill Capital New York $466M AUM

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return